ACVRL1 and neoplasm: In addition to the ubiquitously expressed TβRs (TβRII and ALK5), the activin receptor-like kinase-1 (ALK1) has more distinct expression properties as it is preferentially expressed on proliferating vascular endothelial cells; thus inhibition of ALK1 might block tumor-induced angiogenesis.